Home › Companies › CASTLE BIOSCIENCES INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CASTLE BIOSCIENCES INC.’s Form 8-K, filed May 23, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 22, 2025: 6 items on CASTLE BIOSCIENCES INC.’s Form 8-K, filed May 23, 2025: 3 elected · 3 approved.
Significant dissent: 1 director (36.4% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore CASTLE BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are CASTLE BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 23, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Kimberlee S. Caple | 13,580,035 | -- | -- | 7,764,145 | 2,358,393 | 64% | Elected | — |
| Elect Director: G. Bradley Cole | 19,839,019 | -- | -- | 1,505,161 | 2,385,393 | 93% | Elected | — |
| Elect Director: Derek J. Maetzold | 19,909,583 | -- | -- | 1,434,597 | 2,385,393 | 93% | Elected | — |
| 2. Ratification of the Selection of Independent Registered Public Accounting Firm | 23,690,098 | 20,837 | 18,638 | -- | -- | 99.9% | Approved | — |
| 3. Approval of the Compensation of the Company's Named Executive Officers | 19,986,768 | 1,314,254 | 43,158 | -- | 2,385,393 | 94% | Approved | — |
| 4. Approval of Amendment and Restatement of the Company's Amended and Restated Certificate of Incorporation | 20,327,249 | 976,000 | 40,931 | -- | 2,385,393 | 95% | Approved | — |
Source: CASTLE BIOSCIENCES INC., Form 8-K, filed with the SEC on May 23, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
219 asset managers disclosed a vote on at least one CASTLE BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
64% Majority: yes · of votes cast
Description as filed by funds: To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholders: Kimberlee S. Caple
CASTLE BIOSCIENCES INC.’s own tally for this item (“Elect Director: Kimberlee S. Caple”): 13,580,035 for, 7,764,145 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Election of Directors The Company's stockholders elected the three individuals listed below as Class III Directors, each to serve until the Company's 2028 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 64% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,000,208 | 0 | 0 | 9,824 | For |
| BlackRock | 1,512,363 | 0 | 0 | 0 | For |
| Fidelity | 588,052 | 0 | 0 | 551,200 | Mixed |
| Dimensional | 0 | 0 | 0 | 1,041,888 | Withhold |
| WASATCH FUNDS TRUST | 943,715 | 0 | 0 | 0 | For |
| TIAA | 691,291 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 0 | 622,300 | Withhold |
| BUFFALO FUNDS | 278,314 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 258,681 | 0 | 0 | 0 | For |
| Charles Schwab | 242,255 | 0 | 0 | 0 | For |
| Allspring | 0 | 0 | 0 | 159,695 | Withhold |
| Nuveen | 156,214 | 0 | 0 | 0 | For |
| State Street | 121,022 | 0 | 0 | 176 | For |
| SEI | 82,675 | 0 | 0 | 0 | For |
| Equitable | 45,963 | 0 | 0 | 33,370 | Mixed |
| American Century | 0 | 0 | 0 | 73,954 | Withhold |
| Hartford | 65,409 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0 | 0 | 0 | 49,100 | Withhold |
| Exchange Place Advisors Trust | 48,810 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,734 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 42,511 | Withhold |
| Putnam | 41,977 | 0 | 0 | 0 | For |
| Lincoln Financial | 19,200 | 0 | 0 | 19,135 | Mixed |
| Goldman Sachs | 0 | 0 | 0 | 34,964 | Withhold |
| Northern Trust | 0 | 0 | 0 | 30,591 | Withhold |
Fund voting reports, all 66 managers: 7,286,182 for, 2,777,128 withheld, 25,732 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SHELTON CAPITAL MANAGEMENT | 0 | 0 | 0 | 114,008 | Withhold |
Institutional-manager reports, all 1 managers: 114,008 withheld.
Combines 6 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To elect the three Class III directors listed below to hold office until the 2028 Annual Meeting of Stockholders: G. Bradley Cole
CASTLE BIOSCIENCES INC.’s own tally for this item (“Elect Director: G. Bradley Cole”): 19,839,019 for, 1,505,161 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Election of Directors The Company's stockholders elected the three individuals listed below as Class III Directors, each to serve until the Company's 2028 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,010,032 | 0 | 0 | 0 | For |
| BlackRock | 1,512,363 | 0 | 0 | 0 | For |
| Fidelity | 1,139,252 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 1,041,888 | Withhold |
| WASATCH FUNDS TRUST | 943,715 | 0 | 0 | 0 | For |
| TIAA | 691,291 | 0 | 0 | 0 | For |
| Principal | 622,300 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 278,314 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 258,681 | 0 | 0 | 0 | For |
| Charles Schwab | 242,255 | 0 | 0 | 0 | For |
| Allspring | 159,695 | 0 | 0 | 0 | For |
| Nuveen | 156,214 | 0 | 0 | 0 | For |
| State Street | 121,198 | 0 | 0 | 0 | For |
| Equitable | 85,560 | 0 | 0 | 33,370 | Mixed |
| SEI | 82,675 | 0 | 0 | 0 | For |
| American Century | 73,954 | 0 | 0 | 0 | For |
| Hartford | 65,409 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 49,100 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 48,810 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,734 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 42,511 | 0 | 0 | 0 | For |
| Putnam | 41,977 | 0 | 0 | 0 | For |
| Lincoln Financial | 35,735 | 0 | 0 | 2,600 | Mixed |
| Goldman Sachs | 34,964 | 0 | 0 | 0 | For |
| Northern Trust | 30,591 | 0 | 0 | 0 | For |
Fund voting reports, all 65 managers: 9,009,157 for, 1,090,265 withheld, 8,217 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SHELTON CAPITAL MANAGEMENT | 114,008 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 114,008 for.
Combines 5 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: DIRECTOR: DEREK MAETZOLD
CASTLE BIOSCIENCES INC.’s own tally for this item (“Elect Director: Derek J. Maetzold”): 19,909,583 for, 1,434,597 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Election of Directors The Company's stockholders elected the three individuals listed below as Class III Directors, each to serve until the Company's 2028 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 26 asset managers below reported 2,386,880 for, 5,063 withheld, 8,217 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,512,363 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 278,314 | 0 | 0 | 0 | For |
| Charles Schwab | 242,255 | 0 | 0 | 0 | For |
| SEI | 82,675 | 0 | 0 | 0 | For |
| Hartford | 65,409 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 48,810 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,734 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 17,153 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 16,778 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,595 | 0 | 0 | 0 | For |
| Global X | 15,441 | 0 | 0 | 0 | For |
| JPMorgan | 15,275 | 0 | 0 | 0 | For |
| John Hancock | 9,215 | 0 | 1,179 | 0 | Mixed |
| Bridge Builder Trust | 9,584 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 8,300 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 6,607 | 0 | Abstain |
| AuguStar | 0 | 0 | 0 | 5,063 | Withhold |
| NORTHERN LIGHTS FUND TRUST II | 1,025 | 0 | 0 | 0 | For |
| Nationwide | 1,024 | 0 | 0 | 0 | For |
| NEW COVENANT FUNDS | 730 | 0 | 0 | 0 | For |
| Texas Capital Funds Trust | 694 | 0 | 0 | 0 | For |
| Allianz | 0 | 0 | 431 | 0 | Abstain |
| Innovator ETFs Trust | 224 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 171 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
Showing the 25 largest of 26 asset managers. All 26 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: To approve the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company to the maximum extent permitted by Delaware law.
CASTLE BIOSCIENCES INC.’s own tally for this item (“4. Approval of Amendment and Restatement of the Company's Amended and Restated Certificate of Incorporation”): 20,327,249 for, 976,000 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the A&R Charter to limit the liability of certain officers of the company to the maximum extent permitted by the DGCL.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,010,032 | 0 | 0 | 0 | For |
| BlackRock | 1,512,363 | 0 | 0 | 0 | For |
| Fidelity | 1,139,252 | 0 | 0 | 0 | For |
| Dimensional | 1,041,888 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 943,715 | 0 | 0 | 0 | For |
| TIAA | 691,291 | 0 | 0 | 0 | For |
| Principal | 622,300 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 278,314 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 258,681 | 0 | 0 | 0 | For |
| Charles Schwab | 242,255 | 0 | 0 | 0 | For |
| Allspring | 159,695 | 0 | 0 | 0 | For |
| Nuveen | 156,214 | 0 | 0 | 0 | For |
| State Street | 121,168 | 30 | 0 | 0 | For |
| SEI | 0 | 82,675 | 0 | 0 | Against |
| Equitable | 79,333 | 0 | 0 | 0 | For |
| American Century | 73,954 | 0 | 0 | 0 | For |
| Hartford | 65,409 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 49,100 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 0 | 48,810 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 44,734 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 42,511 | 0 | 0 | 0 | For |
| Putnam | 41,977 | 0 | 0 | 0 | For |
| Lincoln Financial | 38,335 | 0 | 0 | 0 | For |
| Goldman Sachs | 34,964 | 0 | 0 | 0 | For |
| Northern Trust | 30,591 | 0 | 0 | 0 | For |
Fund voting reports, all 66 managers: 9,882,181 for, 181,309 against, 26,063 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SHELTON CAPITAL MANAGEMENT | 114,008 | 0 | 0 | 0 | For |
| Jackson Creek Investment Advisors LLC | 1,931 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 115,939 for.
Combines 12 wordings of this item as funds reported it.
94% Approved · of votes cast
Prior year: 98.5% for (May 23, 2024 meeting) ▼ 4.7 pts
Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.
CASTLE BIOSCIENCES INC.’s own tally for this item (“3. Approval of the Compensation of the Company's Named Executive Officers”): 19,986,768 for, 1,314,254 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Approval of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,010,032 | 0 | 0 | 0 | For |
| BlackRock | 1,512,363 | 0 | 0 | 0 | For |
| Fidelity | 1,139,252 | 0 | 0 | 0 | For |
| Dimensional | 1,041,888 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 943,715 | 0 | 0 | 0 | For |
| TIAA | 691,291 | 0 | 0 | 0 | For |
| Principal | 622,300 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 278,314 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 258,681 | 0 | 0 | 0 | For |
| Charles Schwab | 242,255 | 0 | 0 | 0 | For |
| Allspring | 159,695 | 0 | 0 | 0 | For |
| Nuveen | 156,214 | 0 | 0 | 0 | For |
| State Street | 121,198 | 0 | 0 | 0 | For |
| SEI | 82,675 | 0 | 0 | 0 | For |
| Equitable | 79,333 | 0 | 0 | 0 | For |
| American Century | 73,954 | 0 | 0 | 0 | For |
| Hartford | 65,409 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 49,100 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 48,810 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,734 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 42,511 | 0 | 0 | 0 | For |
| Putnam | 41,977 | 0 | 0 | 0 | For |
| Lincoln Financial | 38,335 | 0 | 0 | 0 | For |
| Goldman Sachs | 34,964 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 30,640 | 0 | 0 | 0 | For |
Fund voting reports, all 67 managers: 10,094,130 for, 26,063 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,250,365 | 0 | 0 | 0 | For |
| Portolan Capital Management, LLC | 1,222,723 | 0 | 0 | 0 | For |
| WASATCH ADVISORS LP | 997,893 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 911,678 | 0 | 0 | 0 | For |
| Nuveen | 891,445 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 649,753 | 0 | 0 | 0 | For |
| Wellington | 640,924 | 0 | 0 | 0 | For |
| State Street | 589,032 | 0 | 0 | 0 | For |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 561,653 | 0 | 0 | 0 | For |
| Park West Asset Management LLC | 556,485 | 0 | 0 | 0 | For |
| Renaissance | 402,831 | 0 | 0 | 0 | For |
| Allianz | 0 | 392,643 | 0 | 0 | Against |
| BRAIDWELL LP | 365,247 | 0 | 0 | 0 | For |
| Point72 | 361,417 | 0 | 0 | 0 | For |
| PALISADE CAPITAL MANAGEMENT, LP | 307,580 | 0 | 0 | 0 | For |
| Charles Schwab | 242,258 | 0 | 0 | 0 | For |
| Northern Trust | 225,569 | 0 | 0 | 0 | For |
| Two Sigma | 167,833 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | 163,159 | 0 | 0 | Against |
| DE Shaw | 151,587 | 0 | 0 | 0 | For |
| Dimensional | 123,471 | 0 | 0 | 0 | For |
| SHELTON CAPITAL MANAGEMENT | 114,008 | 0 | 0 | 0 | For |
| Allspring | 111,175 | 0 | 0 | 0 | For |
| Orion Porfolio Solutions, LLC | 105,895 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 100,450 | 0 | 0 | 0 | For |
Institutional-manager reports, all 170 managers: 12,628,831 for, 766,155 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 99.2% for (May 23, 2024 meeting) ▲ 0.7 pts
Description as filed by funds: To ratify the selection of KPMG LLP by the Audit Committee of our Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2025.
CASTLE BIOSCIENCES INC.’s own tally for this item (“2. Ratification of the Selection of Independent Registered Public Accounting Firm”): 23,690,098 for, 20,837 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection of KPMG LLP by the Audit Committee of the Company's Board of Directors as the Company's independent registered public accounting firm for the fiscal year ending December …”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,010,032 | 0 | 0 | 0 | For |
| BlackRock | 1,512,363 | 0 | 0 | 0 | For |
| Fidelity | 1,139,252 | 0 | 0 | 0 | For |
| Dimensional | 1,041,888 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 943,715 | 0 | 0 | 0 | For |
| TIAA | 691,291 | 0 | 0 | 0 | For |
| Principal | 622,300 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 278,314 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 258,681 | 0 | 0 | 0 | For |
| Charles Schwab | 242,255 | 0 | 0 | 0 | For |
| Allspring | 159,695 | 0 | 0 | 0 | For |
| Nuveen | 156,214 | 0 | 0 | 0 | For |
| State Street | 121,198 | 0 | 0 | 0 | For |
| SEI | 82,675 | 0 | 0 | 0 | For |
| Equitable | 79,333 | 0 | 0 | 0 | For |
| American Century | 73,954 | 0 | 0 | 0 | For |
| Hartford | 65,409 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 49,100 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 48,810 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,734 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 42,511 | 0 | 0 | 0 | For |
| Putnam | 41,977 | 0 | 0 | 0 | For |
| Lincoln Financial | 38,335 | 0 | 0 | 0 | For |
| Goldman Sachs | 34,964 | 0 | 0 | 0 | For |
| Northern Trust | 30,591 | 0 | 0 | 0 | For |
Fund voting reports, all 66 managers: 10,084,155 for, 335 against, 5,063 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SHELTON CAPITAL MANAGEMENT | 114,008 | 0 | 0 | 0 | For |
| Jackson Creek Investment Advisors LLC | 1,931 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 115,939 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 28,844,937 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 6.97% |
| 2 | BlackRock | 5.24% |
| 3 | Fidelity | 3.95% |
| 4 | Dimensional | 3.61% |
| 5 | WASATCH FUNDS TRUST | 3.27% |
| 6 | TIAA | 2.40% |
| 7 | Principal | 2.16% |
| 8 | BUFFALO FUNDS | 0.96% |
| 9 | Columbia Threadneedle | 0.90% |
| 10 | Charles Schwab | 0.84% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 4.33% |
| 2 | Portolan Capital Management, LLC | 4.24% |
| 3 | WASATCH ADVISORS LP | 3.46% |
| 4 | PRINCIPAL GLOBAL INVESTORS | 3.16% |
| 5 | Nuveen | 3.09% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.25% |
| 7 | Wellington | 2.22% |
| 8 | State Street | 2.04% |
| 9 | SCHRODER INVESTMENT MANAGEMENT GROUP | 1.95% |
| 10 | Park West Asset Management LLC | 1.93% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 2,983,540 | 10.34% | Form 13F, quarter ended March 31, 2025 |
| RTW Investments, LP | 2,758,335 | 9.56% | Schedule 13G, filed May 15, 2026 |
| Vanguard Group | 2,047,565 | 7.10% | Form 13F, quarter ended March 31, 2025 |
| Wasatch Advisors, LP. | 1,796,088 | 6.23% | Proxy statement (DEF 14A), proxy filed April 9, 2025 |
| Principal Financial Group, Inc. | 1,435,665 | 4.98% | Proxy statement (DEF 14A), proxy filed April 9, 2025 |
| Dimensional Fund Advisors LP | 1,143,799 | 3.97% | Schedule 13G, filed January 21, 2026 |
| Derek J. Maetzold | 900,885 | 3.12% | Proxy statement (DEF 14A), proxy filed April 9, 2025 |
| Wellington Management | 828,528 | 2.87% | Form 13F, quarter ended March 31, 2025 |
| State Street | 715,028 | 2.48% | Form 13F, quarter ended March 31, 2025 |
| Renaissance Technologies | 701,200 | 2.43% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 28,844,937 shares outstanding, as reported by CASTLE BIOSCIENCES INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At CASTLE BIOSCIENCES INC.'s shareholder meeting held May 22, 2025, in the 2024-2025 proxy season, 219 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 1,389 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers, as… — CASTLE BIOSCIENCES INC.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CASTLE BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 23, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CASTLE BIOSCIENCES INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
CASTLE BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “CASTLE BIOSCIENCES (CSTL) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/castle-biosciences-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.